Liz Parrish Releases How I Became a GMO and Why You Will Too, a Firsthand Account of Gene Therapy, Aging, and the Future of Human Longevity
BioViva CEO shares the personal journey that led her from searching for answers to her son's Type 1 diabetes to becoming one of the first people to undergo experimental gene therapies targeting biological aging. PACIFIC, Wash., Oct. 27, 2026 /PRNewswire/ -- Elizabeth "Liz" Parrish,...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.